The virus spreads through direct contact, not through the air.
Em São Paulo, as autoridades de saúde investigam um segundo caso suspeito de Ebola em 2026 — desta vez, uma mulher de 31 anos que retornou do trabalho na República Democrática do Congo e adoeceu dias após pisar em solo brasileiro. O caso não confirma a presença do vírus no país, mas ecoa uma verdade antiga: em um mundo de fronteiras porosas, a vigilância é a primeira forma de cuidado coletivo. Enquanto o Instituto Adolfo Lutz analisa as amostras, o Brasil observa com atenção o que acontece a milhares de quilômetros de distância — e se prepara para o que pode, ou não, chegar.
- Uma mulher de 31 anos, recém-chegada da província de North Kivu, foi internada em isolamento no Emílio Ribas após desenvolver febre e diarreia três dias depois de desembarcar no Brasil.
- É o segundo caso suspeito em poucas semanas: o primeiro, em um homem de 37 anos com histórico semelhante, foi descartado como Ebola e identificado como meningite meningocócica.
- A OMS declarou surto da cepa Bundibugyo no Congo e em Uganda, com 18 mortes confirmadas e centenas de casos ainda sob investigação — o que mantém os sistemas de saúde globais em estado de alerta.
- São Paulo intensificou a vigilância epidemiológica e treinou mais de 1.100 profissionais de saúde para identificar e responder a casos suspeitos em toda a rede pública.
- Autoridades reforçam que o risco de introdução do Ebola no Brasil permanece muito baixo, mas aguardam os resultados laboratoriais definitivos do Instituto Adolfo Lutz antes de qualquer conclusão.
São Paulo investiga um segundo caso suspeito de Ebola em 2026: uma mulher de 31 anos que trabalhava na República Democrática do Congo desembarcou no Brasil em 6 de junho e, três dias depois, desenvolveu febre e diarreia. Após atendimento inicial em hospital particular, foi transferida para o Instituto de Infectologia Emílio Ribas, onde permanece isolada e estável, aguardando os resultados do Instituto Adolfo Lutz.
A investigação foi aberta porque a paciente preenche os critérios clínicos para caso suspeito: viagem recente à província de North Kivu, onde o vírus circula ativamente, somada a sintomas compatíveis. Um teste rápido para malária deu negativo. Nenhum caso de Ebola foi confirmado no país.
O episódio não é isolado. No início de junho, um homem de 37 anos com histórico semelhante foi testado e o Ebola foi descartado — o diagnóstico final apontou meningite meningocócica. O padrão de viajantes retornando da zona de surto com febre levou o estado a reforçar sua capacidade de resposta: mais de 1.100 profissionais foram treinados pelo Centro de Vigilância Epidemiológica para reconhecer e manejar casos suspeitos.
O pano de fundo é o surto declarado pela OMS da cepa Bundibugyo no Congo e em Uganda, com 18 mortes confirmadas entre 134 casos e centenas ainda sob investigação. O Ebola não se transmite pelo ar — o contágio ocorre por contato direto com fluidos de pessoas já sintomáticas — e as autoridades brasileiras mantêm a avaliação de risco muito baixo para a introdução da doença no país. Ainda assim, a vigilância segue ativa.
São Paulo's health authorities are investigating a second suspected case of Ebola this year, this time in a 31-year-old Brazilian woman who returned from work in the Democratic Republic of Congo and fell ill shortly after arriving home. She landed in Brazil on June 6 and began running a fever with diarrhea three days later. After initial treatment at a private hospital in the capital, she was transferred to the Instituto de Infectologia Emílio Ribas, the state's leading infectious disease facility, where she remains isolated while awaiting laboratory confirmation. Her condition is currently stable.
The investigation opened because the woman meets the clinical criteria for a suspected Ebola case: recent travel to North Kivu province, where the virus is actively circulating, combined with symptoms consistent with the disease. A rapid malaria test came back negative. The Instituto Adolfo Lutz, the state's reference laboratory, is now conducting the definitive analysis that will either confirm or rule out the infection. Health officials have been careful to note that no Ebola infection has been confirmed.
This is the second such investigation in as many weeks. In early June, a 37-year-old man who had also returned from the Democratic Republic of Congo was tested after developing similar symptoms. Those tests ruled out Ebola but identified meningococcal meningitis instead, caused by the bacterium Neisseria meningitidis. The pattern of travelers returning from the outbreak zone with fever has prompted São Paulo's health department to sharpen its readiness across the entire state health system.
In response to these cases, the state has intensified epidemiological surveillance. More than 1,100 health professionals recently completed training organized by the Center for Epidemiological Surveillance to recognize, prevent, and respond to suspected cases. Treatment and monitoring protocols have been updated across the public health network. Officials stress that the overall risk of Ebola entering Brazil or South America remains very low.
The virus spreads through direct contact with blood, bodily secretions, fluids, or tissues from infected people who are already symptomatic. Unlike respiratory diseases, Ebola does not travel through the air. The hallmark symptoms include high fever, severe headache, muscle pain, fatigue, nausea, vomiting, diarrhea, and abdominal pain. Transmission risk peaks in the disease's later stages, when contact with contaminated fluids becomes more likely.
The concern driving this vigilance is real. About two weeks before this second case was identified, the World Health Organization declared an outbreak of the Bundibugyo strain of Ebola in the Democratic Republic of Congo and Uganda. The outbreak has produced 18 confirmed deaths among 134 confirmed cases, with an additional 223 deaths and 906 cases still under investigation. The numbers underscore why health systems in countries with international travel connections are watching closely, even as they maintain confidence that the disease will not take hold in Brazil.
Notable Quotes
The risk of introduction of the disease in Brazil and South America continues to be classified as very low.— São Paulo State Health Department
The Hearth Conversation Another angle on the story
Why does a single case in São Paulo warrant this level of response when the overall risk is so low?
Because the moment someone crosses a border with a virus like this, the calculus changes. You're not managing an abstract threat anymore—you're managing a real person in a real hospital. The training, the protocols, the lab work—that's the system proving it can catch what needs to be caught.
The first case turned out to be meningitis. Does that make the second investigation feel less urgent?
Not at all. It actually validates the system. They didn't assume anything. They tested. The fact that the first one was something else doesn't mean the second one is. Each case has to be treated as if it could be the one.
What's the difference between someone getting sick in São Paulo versus someone getting sick in North Kivu?
Everything. In North Kivu, the virus is already there, spreading through a population with limited resources. In São Paulo, you have isolation wards, trained staff, lab capacity, and a health system watching. The woman is isolated. The contacts are being traced. That's the difference between an outbreak and a contained case.
Why train over a thousand health workers if the risk is very low?
Because very low risk doesn't mean no risk. And if it does happen, the first hours matter enormously. You want every doctor, every nurse, every person in the system to recognize it instantly. That's not panic—that's preparation.
What happens if the test comes back positive?
Then the protocols activate. Contacts are traced. The isolation continues. The case is reported to international health authorities. Brazil's health system has done this before with other diseases. The machinery exists. But everyone is hoping the test comes back negative.